Working… Menu
Trial record 1 of 1 for:    NCT02466243
Previous Study | Return to List | Next Study

Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02466243
Recruitment Status : Terminated (Sponsor terminated open-label extension.)
First Posted : June 9, 2015
Last Update Posted : March 29, 2021
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
University of Pennsylvania
Information provided by (Responsible Party):
Corbus Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2017
Actual Study Completion Date : January 29, 2021
Certification/Extension First Submitted : January 18, 2019